Clearside Biomedical Ipo

At Manningham Medical Centre, you can find all the data about Clearside Biomedical Ipo. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

Clearside BioMedical, Inc. has completed an IPO in the …

https://www.marketscreener.com/quote/stock/CLEARSIDE-BIOMEDICAL-INC-28377249/news/Clearside-BioMedical-Inc-has-completed-an-IPO-in-the-amount-of-50-4-million-35434672/

Clearside BioMedical, Inc. has completed an IPO in the amount of $50.4 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: …

Clearside Biomedical Announces Potential Pricing for IPO - Yahoo!

https://finance.yahoo.com/news/clearside-biomedical-announces-potential-pricing-123555795.html

Clearside Biomedical expects to price 4 million shares in the range of $14 to $16 per share in an initial public offering valued up to more than $73 million.

Clearside Biomedical, Inc. Announces Pricing of Initial Public …

https://ir.clearsidebio.com/news-releases/news-release-details/clearside-biomedical-inc-announces-pricing-initial-public

ALPHARETTA, Ga., June 01, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company …

Clearside Biomedical Changes Up Pricing for IPO - Yahoo!

https://finance.yahoo.com/news/clearside-biomedical-changes-pricing-ipo-124009923.html

Clearside Biomedical expects to price more than 7 million shares at $7 per share for an initial public offering valued up to nearly $58 million.

Clearside Biomedical Files for IPO - Yahoo!

https://finance.yahoo.com/news/clearside-biomedical-files-ipo-141029273.html

Clearside Biomedical has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). …

Clearside Biomedical: A Pivotal 2022 Ahead

https://seekingalpha.com/article/4501137-clearside-biomedical-pivotal-2022-ahead

The company made a net income of $376,000 for the year ending December 31, 2021. Clearside, as of December 31, 2021, announced cash and cash equivalents …

Clearside Biomedical

https://clearsidebio.com/

Clearside Biomedical clearsidebio 2022-05-22T00:09:17+00:00. LEARN ABOUT SUPRACHOROIDAL ADMINISTRATION. FIRST & ONLY FDA APPROVED PRODUCT …

Clearside Biomedical Announces Positive 6-Month Results from …

https://finance.yahoo.com/news/clearside-biomedical-announces-positive-6-120500797.html

Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the ... which focuses on psychotropic drugs and had its initial …

News | Investor Relations | Clearside Biomedical, Inc.- IR Site

https://ir.clearsidebio.com/news-releases

Clearside Biomedical Announces Leadership Team Update. Feb 2 2023. Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with …

Corporate Overview – Clearside Biomedical

https://clearsidebio.com/about/

Clearside Biomedical is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). The platform …

Need more information about Clearside Biomedical Ipo?

At Manningham Medical Centre, we collected data on more than just Clearside Biomedical Ipo. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.